Intuitive Surgical, Inc.
As of Fiscal Year 2025 (ended December 31, 2025)
Key KPIs at a Glance
| Metric | Value |
|---|---|
| Total revenue (FY2025) | $10.065 billion, up 20.5% year-over-year |
| GAAP operating income (FY2025) | $2.946 billion, 29.3% operating margin |
| Net income attributable to Intuitive (FY2025) | $2.856 billion, up from $2.335 billion in FY2024 |
| Da Vinci procedure volume growth (FY2025) | Approximately 18% year-over-year |
| Installed base of da Vinci surgical systems (as of Dec 31, 2025) | 11,106 systems worldwide |
| Installed base of Ion endoluminal systems (as of Dec 31, 2025) | 995 systems worldwide |
| Employees (as of Dec 31, 2025) | 17,021, up 8.8% year-over-year |
| 2026 outlook | Management guided to da Vinci procedure growth of approximately 13%-15% for FY2026 |
Sources: Revenue-by-category, operating income, net income, procedure growth and installed-base figures are from Intuitive Surgical's Q4/FY2025 earnings release (SEC 8-K exhibit, filed January 2026). Employee headcount is the company's 10-K-disclosed December 31, 2025 figure. No specifically-sourced, precisely-quantified third-party market-share estimate for Intuitive Surgical's core soft-tissue robotic surgery business was found with enough rigor to include here (published estimates range broadly from roughly 60% to 80% depending on market definition and source), so a market-share pie was omitted per methodology.